Agios Pharmaceuticals, Inc. Common Stock (NASDAQ: AGIO) last traded at $30.82, down 3.11% on the session. The quote above updates while this page is open; the figures below are drawn from Agios Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Agios Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker AGIO. Its market capitalisation is $1.84 billion.
Valuation measures for Agios Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.84B |
|---|---|
| Enterprise value | $1.82B |
| Price / sales | 18.71 |
| Price / book | 1.79 |
| Beta | 0.45 |
Trailing-twelve-month figures tagged in Agios Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $98.34M |
|---|---|
| Net income (TTM) | -$411.29M |
| EPS (TTM) | -$7.02 |
| Gross margin | 91.99% |
| Operating margin | -466.78% |
| Return on equity | -40.09% |
| Cash | $99.65M |
Range and volume for AGIO over the past 52 weeks.
| 52-week high | $46.00 |
|---|---|
| 52-week low | $22.24 |
| Volume | 647.8K |
| Average volume | 1.07M |
| Previous close | $31.81 |
Invest a chosen dollar amount in Agios Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell AGIO.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.